Department of Neurosurgery, Stanford University School of Medicine, Stanford, California, USA.
Int J Neurosci. 2022 Apr;132(4):413-420. doi: 10.1080/00207454.2020.1818742. Epub 2020 Sep 10.
Intracranial meningiomas are the most common primary tumors of the central nervous system. How socioeconomic status (SES) impacts treatment access and outcomes for brain tumor subtypes is an emerging area of research. Few studies have examined the relationship between SES and meningioma survival and management with reference to relevant clinical factors, including age at diagnosis. We studied the independent effects of SES on receiving surgery and survival probability in patients with intracranial meningioma.
54,282 patients diagnosed with intracranial meningioma between 2003 and 2012 from the Surveillance, Epidemiology, and End Results (SEER) Program at the National Cancer Institute database were included. Patient SES was divided into tertiles. Patient age groups included 'older' (>65, the median patient age) and 'younger'. Multivariable linear regression and Cox proportional hazards model were used with SAS v9.4. Results were adjusted for race, sex, and tumor grade. Kaplan-Meier survival curves were constructed according to SES tertiles and age groups.
Meningioma prevalence increased with higher SES tertile. Higher SES tertile was also associated with younger age at diagnosis (OR = 0.890, < 0.05), an increased likelihood of undergoing gross total resection (GTR) (OR = 1.112, < 0.05), and a trend toward greater 5-year survival probability (HR = 1.773, = 0.0531). Survival probability correlated with younger age at diagnosis (HR = 2.597, < 0.001), but not with GTR receipt.
The findings from this national longitudinal study on patients with meningioma suggest that SES affects age at diagnosis and treatment access for intracranial meningiomas patients. Further studies are required to understand and address the mechanisms underlying these disparities.
颅内脑膜瘤是中枢神经系统最常见的原发性肿瘤。社会经济地位(SES)如何影响脑肿瘤亚型的治疗机会和结果是一个新兴的研究领域。很少有研究探讨 SES 与脑膜瘤生存率和管理之间的关系,并参考了包括诊断时年龄在内的相关临床因素。我们研究了 SES 对颅内脑膜瘤患者接受手术和生存概率的独立影响。
纳入了来自国家癌症研究所数据库的监测、流行病学和最终结果(SEER)计划在 2003 年至 2012 年间诊断为颅内脑膜瘤的 54282 名患者。患者 SES 分为三分位。患者年龄组包括“年龄较大”(>65 岁,中位患者年龄)和“年龄较小”。使用 SAS v9.4 进行多变量线性回归和 Cox 比例风险模型。结果根据 SES 三分位和年龄组进行调整。根据 SES 三分位和年龄组构建 Kaplan-Meier 生存曲线。
脑膜瘤患病率随 SES 三分位升高而增加。SES 三分位较高还与诊断时年龄较小(OR=0.890, < 0.05)、更有可能接受大体全切除(GTR)(OR=1.112, < 0.05)以及 5 年生存率增加的趋势相关(HR=1.773, = 0.0531)。生存概率与诊断时年龄较小相关(HR=2.597, < 0.001),但与 GTR 无关。
这项针对脑膜瘤患者的全国性纵向研究的结果表明,SES 影响颅内脑膜瘤患者的诊断年龄和治疗机会。需要进一步研究以了解和解决这些差异背后的机制。